Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/30/2003CA2482445A1 Amonafide salts
10/30/2003CA2482183A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003CA2482035A1 Novel sodium channel blockers
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481499A1 Use of cyclopamine in the treatment of psoriasis and other skin disorders
10/30/2003CA2481108A1 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003CA2481085A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2466229A1 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/29/2003EP1357184A2 Novel cis-element decoys useful as anti-tumor therapeutics
10/29/2003EP1357125A2 Process for the preparation of halogenated derivatives of vinca alcaloids
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356822A2 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
10/29/2003EP1356820A1 DNA vaccine combined with an inducer of tumor cell apoptosis
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356108A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356107A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356097A2 The anti-neoplastic agent et-743 inhibits trans activation by sxr
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356070A2 Conditionally replicating viral vectors and their use
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
10/29/2003EP1356052A2 Prokaryotically produced antibodies and uses thereof
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356038A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1356036A2 Process and compositions for peptide, protein and peptidomimetic synthesis
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356026A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355917A2 Compositions and methods relating to breast specific genes and proteins
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355903A1 Pyrazole derivatives against tgf overexpression
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives
10/29/2003EP1355870A1 Thiazolamines and their use as tgf-beta inhibitors
10/29/2003EP1355676A2 Protecting therapeutic compositions from host-mediated inactivation
10/29/2003EP1355672A2 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
10/29/2003EP1355671A2 Water-soluble polymer conjugates of triazine derivatives
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355661A2 Tumor vaccine
10/29/2003EP1355658A1 Pyk2 phosphorylation by her3 induces tumor invasion
10/29/2003EP1355649A2 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
10/29/2003EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355634A2 Sn-38 lipid complexes and methods of use
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1153920B1 Quinoline derivatives and quinazoline derivatives
10/29/2003EP1140047B1 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
10/29/2003EP1107940B1 Vitamin d3 mimics
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1007527B1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
10/29/2003EP0983272B1 A new class of benzoporphyrin derivative photoactive compounds
10/29/2003EP0971888B1 2-alkyl-19-nor-vitamin d compounds
10/29/2003EP0951553B1 Adenovirus e4 proteins for inducing cell death
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0444186B2 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
10/29/2003CN1452719A Method for identifying combinations of drugs
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452634A HLA binding peptides and their uses
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452498A 药物活性化合物 Pharmaceutically active compounds
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452485A Cannabinoid drugs
10/29/2003CN1452483A IL-8 receptor antagonists
1 ... 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 ... 2211